Company news

Genetic Signatures Ltd. news in 2026

Genetic Signatures Ltd.'s news releases, calls and decks from 2026, newest first.

View company

Notification regarding unquoted securities - GSS

November 1, 2026

3X Initial Directors Interest Notice

November 1, 2026

BCAL Welcomes Dr John Melki's Appointment to GSS Board

October 28, 2026

Results of 2026 EGM and Appointment of Director

October 27, 2026

Addendum to Notice of Annual General Meeting

October 23, 2026

Update on Commercial Terms for the Proposed Merger with MAP

October 20, 2026

Update on Commercial Terms for Proposed Merger with MAP

October 20, 2026

Response to Media Speculation & BCAL letter to GSS

October 16, 2026

GSS: Response to Media Speculation & BCAL letter to GSS

October 16, 2026

2026 Notice of Annual General Meeting

October 15, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 7, 2026

Becoming a substantial holder

September 28, 2026

Notice of Extraordinary General Meeting

September 23, 2026

GSS Investor Presentation - Proposed Merger with MAP

September 21, 2026

GSS and MAP agree to Commercial Terms for Merger

September 21, 2026

Receipt of Section 249D Notice from BCAL Diagnostics

September 16, 2026

Date of AGM and Closing Date for Director Nominations

September 13, 2026

BDX Holdings of GSS Shares and receipt of Section 249D

September 2, 2026

Final Director's Interest Notice

August 31, 2026

Board Changes

August 30, 2026

Ceasing to be a substantial holder

August 27, 2026

Genetic Signatures and Microba in Merger Discussions

August 25, 2026

Change in Substantial Shareholder Notice for GSS

August 25, 2026

Change in substantial holding

August 25, 2026

FY26 Market Update

August 24, 2026

FY26 Appendix 4G and Corporate Governance Statement

August 24, 2026

FY26 Results Release

August 24, 2026

FY26 Appendix 4E and Annual Report

August 24, 2026

FY 26 Annual Results and Investor Webinar Notification

August 23, 2026

Commercial Testing Commences at Hvidovre Hospital in Denmark

August 20, 2026

GSS responds to the BCAL Diagnostics Announcement

July 2, 2026

BCAL to Acquire Shares in Genetic Signatures

July 1, 2026

Danish Supply Agreement - Additional Information

April 15, 2026

Genetic Signatures Signs Danish Supply Agreement

April 14, 2026

Genetic Signatures Organisational Restructure

March 29, 2026

1H FY26 Results Release

February 25, 2026

1H FY26 Results Presentation

February 25, 2026

1H FY26 Appendix 4D and Half Year Report

February 25, 2026

GSS Appoints Anne Lockwood as Interim Managing Director

February 5, 2026

Genetic Signatures Appoints Maria Halasz as CEO

February 1, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 19, 2026

Calls in 2026

Decks in 2026